CoreLink, a manufacturer of spinal implant systems, acquired Israel-based Expanding Orthopedics, a privately held medical device developer.
Along with the FDA cleared expanding and articulating FLXfit and FLXfit 15 titanium TLIF interbody systems, CoreLink has also acquired a broad array of patents and in-development products addressing the expandable interbody and spinal fusion market.
“This acquisition provides two key benefits for CoreLink and its customers: a very compelling offering in the growing expandable interbody product category and a portfolio of innovative intellectual property from which we can advance spine care,” CoreLink CEO Jay Bartling comments.
FLXfit 15 is a titanium transforaminal lumbar interbody fusion (TLIF) device compatible with minimally invasive surgery. Once in the disc space, it articulates to aid placement along the anterior aspect of the apophyseal ring, providing up to 40mm of footprint length along this critical anterior column. The anterior height of the device can be continuously expanded an additional 4mm to provide up to 15° of lordosis.
A company press release states that CoreLink will provide enhanced support for existing users of both the FLXfit and FLXfit 15 systems, while utilising its vertical integration to quickly incorporate system upgrades for a full commercial re-launch in the third quarter of this financial year.
